3-(Chloromethyl)-1-phenyl-1H,4H,5H,6H-cyclopenta[c]pyrazole

Catalog No. :
ACAKQP961
CAS No. :
123345-76-6
Molecular Formula :
C13H13ClN2
Molecular Weight :
232.71

IUPAC Name:3-(chloromethyl)-1-phenyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole

3-(Chloromethyl)-1-phenyl-1H,4H,5H,6H-cyclopenta[c]pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$128.00Login to see priceInquiryInquiry
100mg95%$181.00Login to see priceInquiryInquiry
250mg95%$252.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Chloromethyl)-1-phenyl-1H,4H,5H,6H-cyclopenta[c]pyrazole
IUPAC Name3-(chloromethyl)-1-phenyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole
MDL No.MFCD14705595
Molecular FormulaC13H13ClN2
Molecular Weight232.71
SMILESClCC1=NN(C2=CC=CC=C2)C3=C1CCC3
InChI KeyJZQCNZOQBXKTDJ-UHFFFAOYSA-N
Synonym3-(Chloromethyl)-1-phenyl-1H,4H,5H,6H-cyclopenta[c]pyrazole;Cyclopentapyrazole, 3-(chloromethyl)-1,4,5,6-tetrahydro-1-phenyl-
CAS No.123345-76-6

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314-H335
Precautionary Statement(s)
P260-P264-P270-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAKQP961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCPZB630 route compound structure diagram
    ACCPZB630591-50-4 In Stock
  4. Then
  5. ACAKQP961 route product structure diagram
    ACAKQP961123345-76-6
Inquiry

2. ACAKQP961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAKQP961 route product structure diagram
    ACAKQP961123345-76-6
Inquiry

Comments (0)